We are live. OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition has officially started in Chicago.
Today, we bring together the sarcoma community for a focused discussion on the latest directions in sarcoma care, starting with Robin Jones and Javier Martin-Broto, from targeted therapies and biomarker testing to IO combinations, T–cell receptor therapy, ADCs, and novel agents.
Happy to have the sarcoma community with us today.
Co-chaired by Sandra D’Angelo and Herbert Loong.
The event’s Foundational partner is Eli Lilly and Company.
The event’s Bronze sponsor is US WorldMeds.
Other articles about ASCO 2026 on OncoDaily.
